Quantcast
Last updated on April 24, 2014 at 21:22 EDT

Latest Masimo Corporation Stories

2012-10-24 07:31:56

IRVINE, Calif., Oct. 24, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that a new study published in Postgraduate Medicine demonstrates noninvasive total hemoglobin (SpHb(®)) measurements from the Pronto have an accuracy similar to those of the most commonly used invasive point-of-care (POC) hematology analyzer (HemoCue(®) 201+, Quest Diagnostics) in outpatient settings.(1) Total hemoglobin (Hb) is one of the most frequently ordered laboratory tests in hospitals, urgent...

2012-10-18 07:26:36

IRVINE, Calif., Oct. 18, 2012 /PRNewswire/ --Masimo (NASDAQ: MASI) announced today that eight significant new clinical studies evaluating Masimo noninvasive patient monitoring technologies were presented at the largest gathering of anesthesiologists in the world, the American Society of Anesthesiologists (ASA) Annual Meeting in Washington, D.C. The following studies highlight the positive clinical outcomes and patient safety impact of Masimo's unique noninvasive measurement technologies,...

2012-10-16 11:26:19

IRVINE, Calif., Oct. 16, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that it will release third quarter financial results for the period ended September 29, 2012, after the market closes on October 30, 2012. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer. A live webcast of the conference call will...

2012-10-15 07:29:38

IRVINE, Calif., Oct. 15, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today limited market release of the Universal ReSposable(TM) Pulse Oximetry Sensor System, offering the Measure-Through Motion and Low Perfusion performance and accuracy of SET(®), as well as the comfort of its single-patient-use adhesive sensors with the cost-effectiveness and environmental advantages of a reusable sensor. The new Universal ReSposable pulse oximetry sensor was created after more than 10...

2012-10-12 07:23:29

IRVINE, Calif., Oct. 12, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced the CE Mark and debut of the new fractional arterial oxygen saturation, SpfO(2)((TM)), parameter through the rainbow(®) Universal ReSposable SuperSensor(TM), the first noninvasive sensor to provide simultaneous monitoring of SpHb(®), SpCO(®), SpMet(®), SpfO(2), SpOC((TM)), Perfusion Index, PVI(®), and Measure-Through Motion and Low Perfusion SpO(2) and pulse rate. (Photo:...

2012-10-09 07:28:32

IRVINE, Calif., Oct. 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced the FDA 510(k) clearance and market release of Masimo's new uSpO(2)(TM) universal pulse oximetry cable for use with GE Healthcare's ApexPro(®) Telemetry Systems. GE Healthcare is the first to integrate Masimo's low power platform with SET(®) Measure-Through Motion and Low Perfusion SpO(2) technology into patient-worn monitors designed for use in ambulatory patient care environments. (Photo:...

2012-10-02 06:26:09

IRVINE, Calif., Oct. 2, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced the conversion of Albany Medical Center (AMC), one of the biggest hospitals in the Capital (N.Y.) Region, to Masimo rainbow SET Pulse CO-Oximetry and sensor technologies for advanced noninvasive patient monitoring capabilities. The conversion equips AMC - which incorporates the 651-bed Albany Medical Center Hospital and the Albany Medical College - with breakthrough rainbow(®) technology that allows...

2012-10-01 02:32:03

DALTON, Ga. and IRVINE, Calif., Oct. 1, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) and Hamilton Medical Center in Dalton, Ga., announced today the hospital has updated to Masimo SET(®) pulse oximetry and rainbow(®) Pulse CO-Oximetry, offering clinicians demonstrably advanced noninvasive and continuous patient monitoring designed to improve patient outcomes while helping hospitals reduce costs. "Hamilton Medical Center prides itself on offering some of the most advanced medical...

2012-09-25 02:28:15

IRVINE, Calif., Sept. 25, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announces first-ever Commitment to Action with the Clinton Global Initiative (CGI) to solve the global problem of maternal mortality and anemia--beginning with Liberia and Uganda. The $1 million, two-year project initially focuses on five villages in Liberia and Uganda--two countries where the epidemics of maternal mortality and anemia are among the worst. Masimo is also working to formalize new partnerships that will...

2012-09-20 10:27:48

IRVINE, Calif., Sept. 20, 2012 /PRNewswire/ -- Masimo Corporation (NASDAQ: MASI) announced today that its Pronto-7(®) handheld noninvasive hemoglobin, arterial oxygen saturation (SpO2), pulse rate, and perfusion index spot-check testing device earned a 2012 GOLD Stevie(®) American Business Award for the Best New Product or Service in the Health & Pharmaceuticals category. (Photo: http://photos.prnewswire.com/prnh/20120109/LA31863) This marks the fourth industry award...